FDA Approved: OXALIPLATIN — Supplemental Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

The FDA approved a supplemental application for oxaliplatin from Fresenius Kabi USA, LLC under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)

Snippet

SUPPL AP for OXALIPLATIN (OXALIPLATIN)